Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 1366 AL 1380

M/EEG-Based Bio-Markers to Predict the MCI and Alzheimer's Disease: A Review From the ML Perspective

Yang S, Bornot JMS, Wong-Lin K, Prasad G.

IEEE Trans Biomed Eng. 2019 Oct;66(10):2924-2935. doi: 10.1109/TBME.2019.2898871. Epub 2019 Feb 12.

Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis

Dhiman K, Blennow K, Zetterberg H, Martins RN, Gupta VB.

Cell Mol Life Sci. 2019 May;76(10):1833-1863. doi: 10.1007/s00018-019-03040-5. Epub 2019 Feb 15.

European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol

Solomon A, Kivipelto M, Molinuevo JL, Tom B, Ritchie CW; EPAD Consortium.

BMJ Open. 2019 Feb 19;8(12):e021017. doi: 10.1136/bmjopen-2017-021017.

Peripheral inflammatory biomarkers in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis

Su C, Zhao K, Xia H, Xu Y.

Psychogeriatrics. 2019 Jul;19(4):300-309. doi: 10.1111/psyg.12403. Epub 2019 Feb 20.

Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative

Sato K, Mano T, Ihara R, Suzuki K, Tomita N, Arai H, Ishii K, Senda M, Ito K, Ikeuchi T, Kuwano R, Matsuda H, Iwatsubo T, Toda T, Iwata A; Alzheimer’s Disease Neuroimaging Initiative, and Japanese Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2019;68(2):777-788. doi: 10.3233/JAD-181115.

The Alzheimer Precision Medicine Initiative

Hampel H, Vergallo A, Perry G, Lista S; Alzheimer Precision Medicine Initiative (APMI).

J Alzheimers Dis. 2019;68(1):1-24. doi: 10.3233/JAD-181121.

ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker

Manzine PR, Ettcheto M, Cano A, Busquets O, Marcello E, Pelucchi S, Di Luca M, Endres K, Olloquequi J, Camins A, Cominetti MR.

Biomed Pharmacother. 2019 May;113:108661. doi: 10.1016/j.biopha.2019.108661. Epub 2019 Mar 2.

The prognostic value of ATN Alzheimer biomarker profiles in cognitively normal individuals

Vos SJB, Duara R.

Neurology. 2019 Apr 2;92(14):643-644. doi: 10.1212/WNL.0000000000007223. Epub 2019 Mar 6.

Rationale and Design of a Clinical Trial of Adapted Tango to Improve Negative Health Impacts in Middle Aged African-American Female Caregivers of Persons with Alzheimer's Disease (ACT Trial)

Hackney ME, McCullough LE, Bay AA, Silverstein HA, Hart AR, Shin RJ, Wharton W.

J Alzheimers Dis. 2019;68(2):767-775. doi: 10.3233/JAD-181130.

Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study

Scaricamazza E, Colonna I, Sancesario GM, Assogna F, Orfei MD, Franchini F, Sancesario G, Mercuri NB, Liguori C.

Neurol Sci. 2019 Jul;40(7):1377-1382. doi: 10.1007/s10072-019-03840-4. Epub 2019 Mar 22.

Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease

Koychev I, Lawson J, Chessell T, Mackay C, Gunn R, Sahakian B, Rowe JB, Thomas AJ, Rochester L, Chan D, Tom B, Malhotra P, Ballard C, Chessell I, Ritchie CW, Raymont V, Leroi I, Lengyel I, Murray M, Thomas DL, Gallacher J, Lovestone S.

BMJ Open. 2019 Mar 23;9(3):e024498. doi: 10.1136/bmjopen-2018-024498.

[Biomarkers of Alzheimer's disease in older and oldest old patients]

Lilamand M, Cognat E, Goutagny S, Hourregue C, Hugon J, Dumurgier J, Paquet C.

Geriatr Psychol Neuropsychiatr Vieil. 2019 Mar 1;17(1):65-72. doi: 10.1684/pnv.2019.0779.

Blood-based molecular biomarkers for Alzheimer's disease

Zetterberg H, Burnham SC.

Mol Brain. 2019 Mar 28;12(1):26. doi: 10.1186/s13041-019-0448-1.

Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial

Forlenza OV, Radanovic M, Talib LL, Gattaz WF.

Br J Psychiatry. 2019 Nov;215(5):668-674. doi: 10.1192/bjp.2019.76.

Evaluation of CD33 as a genetic risk factor for Alzheimer's disease

Estus S, Shaw BC, Devanney N, Katsumata Y, Press EE, Fardo DW.

Acta Neuropathol. 2019 Aug;138(2):187-199. doi: 10.1007/s00401-019-02000-4. Epub 2019 Apr 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias